CICERI, FABIO
 Distribuzione geografica
Continente #
EU - Europa 4.538
NA - Nord America 3.918
AS - Asia 1.590
SA - Sud America 38
OC - Oceania 35
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.143
Nazione #
US - Stati Uniti d'America 3.884
SE - Svezia 2.182
IT - Italia 932
RU - Federazione Russa 845
SG - Singapore 821
CN - Cina 445
FI - Finlandia 137
IE - Irlanda 124
IN - India 100
DE - Germania 98
JP - Giappone 66
NL - Olanda 62
GB - Regno Unito 57
BR - Brasile 32
CA - Canada 31
AU - Australia 28
FR - Francia 27
HK - Hong Kong 27
IR - Iran 24
PK - Pakistan 21
TR - Turchia 18
AT - Austria 15
SA - Arabia Saudita 13
ES - Italia 12
ID - Indonesia 12
IL - Israele 11
ET - Etiopia 8
NZ - Nuova Zelanda 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
KR - Corea 6
RO - Romania 6
BY - Bielorussia 5
DZ - Algeria 5
UA - Ucraina 5
AR - Argentina 4
EG - Egitto 4
NO - Norvegia 4
PH - Filippine 4
TW - Taiwan 4
BE - Belgio 3
MX - Messico 3
PL - Polonia 3
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EU - Europa 2
MA - Marocco 2
MK - Macedonia 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
IQ - Iraq 1
KZ - Kazakistan 1
LT - Lituania 1
ME - Montenegro 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
VN - Vietnam 1
Totale 10.143
Città #
Lawrence 812
Princeton 811
Ashburn 468
Singapore 467
Moscow 340
New York 336
Shanghai 323
Milan 305
Boardman 132
Helsinki 122
Dublin 119
Rome 83
Washington 83
Castelseprio 61
Pune 59
Los Angeles 52
Seattle 49
Chandler 29
Dronten 23
Hong Kong 21
Bologna 20
Campos do Jordao 18
Hanover 17
Lappeenranta 15
London 14
Borås 13
Brescia 12
Genoa 12
Tokyo 12
Turin 12
Clifton 11
Meppel 10
Verona 10
Florence 9
Melbourne 9
Aksum 8
Bergamo 8
Cambridge 8
Hyderabad 8
Naples 8
Shijiazhuang 8
Toronto 8
Ancona 7
Bangkok 7
Boston 7
Brisbane 7
Chicago 7
Elmendorf 7
Gatchina 7
Jakarta 7
Lahore 7
Multan 7
Paris 7
Philadelphia 7
Redwood City 7
San Jose 7
Santa Clara 7
St Petersburg 7
Andover 6
Ankara 6
Beijing 6
Council Bluffs 6
Falls Church 6
Livorno 6
Mountain View 6
Pisa 6
Rockville 6
Segrate 6
Vienna 6
Dalmine 5
Minsk 5
New Haven 5
Osimo 5
Overland Park 5
Padova 5
Palermo 5
Perth 5
Perugia 5
Sharjah 5
Trieste 5
Vittoria 5
Al Qatif 4
Birmingham 4
Chaoyang 4
Chennai 4
Chevy Chase 4
Delhi 4
Elsternwick 4
Izmir 4
Kunming 4
Manchester 4
Michaelnbach 4
Montreal 4
Monza 4
Osio Sotto 4
Palo Alto 4
Quezon City 4
Rovereto 4
Senigallia 4
Siena 4
Totale 5.259
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 189
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 103
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 63
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 58
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 57
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 55
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 53
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 46
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 45
Raman spectroscopy for the assessment of acute myeloid leukemia: A proof of concept study 44
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 40
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 39
null 39
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 38
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 36
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 36
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 34
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 33
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 33
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 33
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 32
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 31
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 31
MicroCLOTS pathophysiology in COVID 19 31
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 30
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 30
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 30
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 30
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 29
After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy 29
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 29
Integrated clinical role of echocardiography in patients with COVID-19 29
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 29
Chronic anticoagulant treatment and risk of mortality in SARS-Cov2 patients: a large population-based study 29
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 29
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 28
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 28
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 28
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 28
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT 27
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 27
Treosulfan-fludarabine-ATG-F based reduced-toxicity conditioning regimen: multicentre "Allo-Treo" study, results in 183 patients with haematological malignancies 27
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 27
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 27
RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study 27
Biobanking for COVID-19 research 27
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies 27
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 26
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 26
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 26
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis 26
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 26
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 26
Subclinical myocardial dysfunction in patients recovered from COVID-19 26
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 26
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 25
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 25
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 25
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 25
High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome 25
COVID-19 mortality rate in nine high-income metropolitan regions 25
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide 25
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 25
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 25
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 25
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 25
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 25
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 24
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 24
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 24
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS 24
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 24
One-year mental health outcomes in a cohort of COVID-19 survivors 24
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 24
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study 23
Testosterone in males with COVID-19: A twelve-month cohort study 23
FAS-based suicide gene strategy for controlled GvHD: An alternative to HSV-tk. 23
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 23
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 23
Severely low testosterone in males with COVID-19: a case-control study 23
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 23
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 23
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial 23
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (Journal of Neuroimmune Pharmacology, (2021), 16, 1, (1-3), 10.1007/s11481-020-09966-z) 23
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 22
Abrogation of GvHD and early immune reconstitution after infusion of HSV-TK engineered donor lymphocytes after haplo-identical hemopoietic stem cell transplantation. 22
Loss of mismatched HLA in leukemia after stem-cell transplantation 22
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 22
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 22
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 22
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 22
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 21
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 21
T cells for suicide gene therapy: Activation, functionality and clinical relevance 21
A new suicide system based on gene transfer of FAS into donor lymphocytes for controlled GVL. 21
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 21
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 21
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 21
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 21
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 21
Totale 3.099
Categoria #
all - tutte 176.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 87 2 1 3 0 0 1 0 1 2 10 4
2020/2021234 6 5 17 68 16 51 20 8 25 1 13 4
2021/2022751 11 2 8 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20243.468 201 226 396 356 327 626 192 273 29 137 188 517
2024/20251.518 1.518 0 0 0 0 0 0 0 0 0 0 0
Totale 11.191